RAFAEL
SAN JUAN GARRIDO
Profesor asociado de Ciencias de la Salud
JULIA
ORIGÜEN SABATER
Profesora asociada de Ciencias de la Salud
Publications dans lesquelles il/elle collabore avec JULIA ORIGÜEN SABATER (18)
2024
-
Predictive value of fecal calprotectin and lactoferrin levels for negative outcomes in Clostridioides difficile infection
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 2, pp. 313-324
2023
2022
-
Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19
International Journal of Infectious Diseases, Vol. 117, pp. 56-64
2021
-
Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study
International Journal of Infectious Diseases, Vol. 105, pp. 487-494
-
Effectiveness of anakinra for tocilizumab-refractory severe COVID-19: A single-centre retrospective comparative study
International Journal of Infectious Diseases, Vol. 105, pp. 319-325
-
Tocilizumab for the treatment of adult patients with severe COVID-19 pneumonia: A single-center cohort study
Journal of Medical Virology, Vol. 93, Núm. 2, pp. 831-842
2018
-
Comparison of the clinical course of Clostridium difficile infection in glutamate dehydrogenase-positive toxin-negative patients diagnosed by PCR to those with a positive toxin test
Clinical Microbiology and Infection, Vol. 24, Núm. 4, pp. 414-421
-
Herpes zoster in kidney transplant recipients: protective effect of anti-cytomegalovirus prophylaxis and natural killer cell count. A single-center cohort study
Transplant International, Vol. 31, Núm. 2, pp. 187-197
-
Impact on mortality of adherence to evidence-based interventions in patients with catheter-related bloodstream infection due to methicillin-sensitive Staphylococcus aureus
Infectious Diseases, Vol. 50, Núm. 11-12, pp. 837-846
-
Post-transplant hypocomplementemia: A novel marker of cardiovascular risk in kidney transplant recipients?
Atherosclerosis, Vol. 269, pp. 204-210
2017
-
Serum sCD30: A promising biomarker for predicting the risk of bacterial infection after kidney transplantation
Transplant Infectious Disease, Vol. 19, Núm. 2
2016
-
A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae
Mayo Clinic Proceedings, Vol. 91, Núm. 10, pp. 1362-1371
-
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae
Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 7, pp. 4159-4169
-
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: A multinational pre-registered cohort study
Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 6, pp. 1672-1680
-
Progressive increase of resistance in Enterobacteriaceae urinary isolates from kidney transplant recipients over the past decade: narrowing of the therapeutic options
Transplant Infectious Disease, Vol. 18, Núm. 4, pp. 575-584
-
Should asymptomatic bacteriuria be systematically treated in kidney transplant recipients? Results from a randomized controlled trial
American Journal of Transplantation, Vol. 16, Núm. 10, pp. 2943-2953
2015
-
Potential role of post-transplant hypogammaglobulinemia in the risk of Clostridium difficile infection after kidney transplantation: a case–control study
Infection, Vol. 43, Núm. 4, pp. 413-422
2012
-
Clinical significance of Candida colonization of intravascular catheters in the absence of documented candidemia
Diagnostic Microbiology and Infectious Disease, Vol. 73, Núm. 2, pp. 157-161